Amneal Pharmaceuticals, Inc. (AMRX)
21.70
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 12, 16:00
21.70
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Free Cash Flow (Quarterly) : 41.55M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 41.55M |
| June 30, 2026 | -143.99M |
| March 31, 2026 | -50.44M |
| December 31, 2025 | 84.15M |
| September 30, 2025 | 95.99M |
| June 30, 2025 | 56.42M |
| March 31, 2025 | -10.91M |
| December 31, 2024 | 94.94M |
| September 30, 2024 | 121.06M |
| June 30, 2024 | 28.20M |
| March 31, 2024 | -24.17M |
| December 31, 2023 | -57.74M |
| September 30, 2023 | 67.37M |
| June 30, 2023 | -23.63M |
| March 31, 2023 | 127.98M |
| December 31, 2022 | -34.76M |
| September 30, 2022 | 42.67M |
| June 30, 2022 | -96.57M |
| March 31, 2022 | 65.55M |
| December 31, 2021 | 44.56M |
| September 30, 2021 | 71.72M |
| June 30, 2021 | -60.24M |
| March 31, 2021 | 136.35M |
| December 31, 2020 | 75.32M |
| September 30, 2020 | 31.58M |
| Date | Value |
|---|---|
| June 30, 2020 | 170.69M |
| March 31, 2020 | 40.61M |
| December 31, 2019 | -55.66M |
| September 30, 2019 | 126.88M |
| June 30, 2019 | -40.55M |
| March 31, 2019 | -126.40M |
| December 31, 2018 | 239.63M |
| September 30, 2018 | 24.66M |
| June 30, 2018 | -118.68M |
| March 31, 2018 | 7.53M |
| December 31, 2017 | 45.67M |
| September 30, 2017 | 33.45M |
| June 30, 2017 | 10.49M |
| March 31, 2017 | 30.31M |
| December 31, 2016 | -40.71M |
| September 30, 2016 | 62.64M |
| June 30, 2016 | -63.30M |
| March 31, 2016 | 63.08M |
| December 31, 2015 | 26.06M |
| September 30, 2015 | 61.43M |
| June 30, 2015 | -66.05M |
| March 31, 2015 | 19.43M |
| December 31, 2014 | -29.07M |
| September 30, 2014 | 27.82M |
| June 30, 2014 | 20.01M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 44.94M |
| Pfizer Inc. | 4.802B |
| Liquidia Corp. | 129.78M |
| Johnson & Johnson | 5.363B |
| Eli Lilly & Co. | 4.157B |